Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer

Madeleine T. King; Martin R. Stockler; Phyllis Butow; Rachel O’Connell; Merryn Voysey; Amit M. Oza; Kim Gillies; Heidi S. Donovan; Rebecca Mercieca-Bebber; Julie Martyn; Katrin Sjoquist; Michael L. Friedlander

doi:10.1097/IGC.0000000000000167

Article info

Ovarian Cancer

Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer

Authors

Madeleine T. King School of Psychology and Psycho-Oncology Cooperative Research Group (PoCoG), University of Sydney, Sydney, NSW, Australia; and PubMed articles Google scholar articles
Martin R. Stockler ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles
Phyllis Butow School of Psychology and Psycho-Oncology Cooperative Research Group (PoCoG), University of Sydney, Sydney, NSW, Australia; and PubMed articles Google scholar articles
Rachel O’Connell ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles
Merryn Voysey ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles
Amit M. Oza Princess Margaret Hospital, Toronto, Ontario, Canada; and PubMed articles Google scholar articles
Kim Gillies ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles
Heidi S. Donovan School of Nursing, University of Pittsburgh, Pittsburgh, PA. PubMed articles Google scholar articles
Rebecca Mercieca-Bebber School of Psychology and Psycho-Oncology Cooperative Research Group (PoCoG), University of Sydney, Sydney, NSW, Australia; and PubMed articles Google scholar articles
Julie Martyn ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles
Katrin Sjoquist ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles
Michael L. Friedlander ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; PubMed articles Google scholar articles

Address correspondence and reprint requests to Madeleine King, PhD, PoCoG, School of Psychology, University of Sydney, NSW 2006, Australia. E-mail: madeleine.king{at}sydney.edu.au.

Citation

King MT, Stockler MR, Butow P, et al

Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer

International Journal of Gynecologic Cancer 2014;24:865-873.

Publication history

Received July 7, 2013
Accepted April 1, 2014
First published June 1, 2014.

Online issue publication

June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password